Finally, NVP-BEZ235 (PI3K/mTOR inhibitor) treatment in combination with docetaxel was more effective than chemotherapy alone at decreasing the human PCSC population and preventing tumor formation in vivo [117]. The gene discussed is MTOR; the disease is neoplasm.